French researchers have discovered a risk marker of lung metastases in women with lung cancer.
If the past few years, the survival rate after breast cancer has improved, it is the risk of relapse and development of metastases in the lungs of concern to doctors.
In a study published in the United States in the Journal of National Cancer Institute, French researchers announced that they have identified a marker of risk of developing metastases in the lungs, in women suffering from breast cancer.
In their previous work, these researchers have identified a family of six genes characteristic of breast cancer metastasizing to the lungs.
This time they have paid attention to one of these genes, it is he who controls the production of a protein (called Kindlin-1) present in breast tumors, which tend to loosen cancer cells of the tumor to then carry the blood vessels and implanted in the lungs.
The objective now is to develop a targeted therapy for women who have been diagnosed at an early stage as "at risk" for metastases, these metastases by blocking upstream.
Saturday, November 5, 2011
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment